Simplified Method for the Isolation and Analysis of Ethynyl Steroids in Urine

Abstract

A simplified procedure for selective isolation of ethynyl steroids from urine is described. Urinary steroids are extracted with Sep-Pak^R C₁₈ and subjected to enzyme hydrolysis. The liberated steroids are extracted with Lipidex 1000 and the eluate from this column is passed through a bed of sulfohydroxypropyl Sephadex LH-20, partly converted into silver form by a wash with aqueous silver nitrate. Ethynyl steroids are eluted with a solution of acetylene in methanol.     

Detection of Sulfamethazine Residues in Milk by High Performance Liquid Chromatography

Abstract

A simple high performance liquid chromatographic (HPLC) procedure for the detection of sulfamethazine residues in milk is described. Milk is extracted with chloroform, the extract evaporated to dryness and then redissolved in potassium phosphate buffer (pH 5.0). The chloroform extract, in buffer, is passed through a cyclobond I solid phase extraction (SPE) column. The SPE column is washed with 10 ml potassium phosphate buffer and then sulfamethazine is eluted with 2 ml aqueous (50%) methanol. The eluent is directly analyzed by HPLC with uv detection at 265 nm. The recoveries ranged from 83.2% to 88.2% in samples fortified between 5 to 40 ppb levels.     

Labetalol Analysis in Human Plasma Using Liquid Chromatography with Electrochemical Detection: Application to Pharmacokinetic Studies

Abstract

Labetalol determination in human plasma by a sensitive (to 2.5 ng/ml) and selective method using liquid chromatography with electrochemical detection is described. Plasma is extracted with diethyl ether under mildly basic (pH 9) conditions, back-extracted into an aqueous acidic buffer, then injected directly on column. Standard curves using propranolol as an internal standard are linear for concentrations from 2.5 to 200 ng/ml. Within-day and between-day reproducibility is satisfactory with coefficient of variation less than 8% for all concentrations. Sample recovery from the extraction is complete at all concentrations. Utility of the method is demonstrated by a pharmacokinetic study in a hypertensive volunteer who received 43.75 mg labetalol by 10 minute intravenous infusion.     

Revised Method for Determination of Aspirin and Salicylic Acid in Human Plasma by High Pressure Liquid Chromatography

Abstract

The method for the analysis of aspirin and salicylic acid in human plasma has been updated to include advances in column technology, extraction procedures and absorbance detection. Aspirin and salicylic acid are extracted from acidified plasma into an organic solvent system containing internal standard. Following controlled evaporation under partial vacuum of the organic extract, the dried down-residue is reconstituted with mobile phase. Chromatography is ion suppression reverse phase on a 5 μm O.D.S. column with detection by absorbance at 237 nm and optional fluorescence. Concentration of aspirin as low as 0.20 μg/ml and salicyclic acid as low as 0.50 μg/ml can be quantitated.     

Column Preconcentration of Palladium Using Phenanthrenequinonedioxime Supported on Naphthalene by Atomic Absorption Spectroscopy

Abstract

A solid chelating compound, phenanthrenequinonedioxime(PQDO) supported on naphthalene provides a rapid and economical means of preconcentration of palladium from the aqueous samples. Palladium forms a complex with PQDO supported on naphthalene in the column at pH 1.2～2.7. The metal complex and naphthalene are dissolved out from the column with 5 ml of dimethylformamide-nitric acid (100+4) and the absorbance is measured atomic absorption spectrometer at 244.7 nm. A calibration curve is linear over the concentration range 1～24 μg of palladium in 5 ml of the final solution. The sensitivity for 1% absorption is 0.126 μg/ml (0.153 μg/ml for the direct AAS method from the aqueous medium). The method has been used for the determination of palladium in various synthetic samples and can be safely applied to the environmental samples too.     

Differential Measurement of Cortisol and Cortisone in Human Saliva by HPLC with Uv Detection

Abstract

Both cortisol and its dehydro metabolite cortisone are present in normal human saliva. A method for differential Measurement of both compounds in 1 ml samples of saliva by HPLC/UV is described. the method uses an extraction column having a cyclodextrin bonded phase to retain the compounds of interest while allowing elution of interfering compounds. A steroid-bearing fraction is eluted from the cyclodextrin column, dried, reconstituted in a weak mobile phase, and injected on a reversed phase HPLC/UV system provided with an injector-mounted reversed phase extraction column. Samples containing corticosteroid concentrations as low as 0.5 ng/ml can be effectively analyzed by this method.     

Manual and automated enrichment procedures for biological samples using lipophilic gels

Aspects of the use of lipophilic gels in manual sample preparation procedures are reviewed. Neutral gels with a controlled hydrophobicity are used for sorbent extraction of non-polar and medium polarity compounds from biological fluids. Acidic amphiphilic compounds can be extracted as ion-pairs with decyltrimethylammonium ions. Solvent or detergent extracts of tissues or faeces can be mixed with hydrophobic gels for transfer of analytes from a solvent to a gel phase, permitting subsequent sample preparation in gel bed systems. Hydrophobic gels, alkyl-bonded silica and polystyrene matrices can be used in series for extraction of compounds with a wide range of polarities. Group fractionations are performed on neutral and ion-exchanging lipophilic gels to yield fractions of neutral, basic and acidic metabolites within selected polarity ranges. Selective isolation of phenolic acids on a strong anion exchanger, of ethynylic steroids on a strong cation exchanger in silver form and of oximes of ketonic steroids on a strong cation exchanger in hydrogen form is possible. A computerized system for automatic sample preparation is also described. It consists of an extraction bed, a cation-exchange column and an anion-exchange column. The pumps and switching valves are arranged so that the columns can operate in series or parallel for isolation of neutral, basic and acidic metabolites of amphiphilic compounds and for regeneration of the column beds. Fractions can be collected, or the effluent from the column beds can be diluted with water to permit sorption on a solid phase. The applicability of the automated method to the analysis of bile acids and metabolites of mono(2-ethylhexyl) phthalate is demonstrated.     

Determination of Pyridostigmine in Human Plasma by High-Performance Liquid Chromatography

Abstract

An easy to perform, specific, reproducible and sensitive high performance liquid chromatographic (HPLC) method to measure pyridostigmine concentration in human plasma was developed and validated. Sample clean-up consists of ion-pair extraction into dichloromethane in the presence of neostigmine as internal standard, followed by back extraction into an aqueous phase. Mean recovery of 110% (with a standard deviation of 10%) was determined for concentrations of 5 – 100 ng/ml. Chromatography on a 125·4 mm CN-propyl column using a mobile phase composed of 10% acetonitrile in 3.5×10^?4M NaH₂PO₄ and UV detection at 270 nm, yields clean chromatograms without any interferences from endogenous plasma components. Using 1 ml plasma samples the method has a limit of detection (LD) of 3 ng/ml, with %CV (precision) and bias (accuracy) ≥ 10% for concentrations in the range of 0–100 ng/ml. The method is being used in human pharmacokinetic studies of oral dosage forms of pyridostigmine.     

Sensitive Determination of Piritramide in Human Plasma by High-Performance Liquid Chromatography

Abstract

A selective and sensitive method for the determination of piritramide in human plasma is described. After addition of 50 μl of 2 M ammonia and 20 μl of aqueous promethazine solution (100 ng/10 μ1) as an internal standard, 1 ml of plasma was extracted with 5 ml of toluene (extraction efficiency: 93.9 × 2.6%; mean × S. D.; n = 5). HPLC was performed with a phenyl hypersil NC-04 column, particle size 5 μm, 250 × 4 mm I. D.; mobile phase: 8 parts of acetonitrile and 2 parts of 10 mM potassium phosphate buffer (pH 3. 3). The flow rate was set to 2 ml/min and the column temperature was 22°C. The assay was linear in a concentration range of 3.75 ? 3000 ng/ml (r = 0.999), with a lower limit of detection of 3 ng/ml. The precision was determined using spiked plasma samples (15 ng/ml; 300 ng/ml), with coefficients of variation of 6.1 and 5.9% (intraday; n = 5) and 6.5 and 0.2% (interday; n = 3). In the range of 5.6 ? 1500 ng/ml, the accuracy of the assay was 2.82%. The method was used for the determination of piritramide plasma concentrations in patients receiving intra- or postoperative analgesia.     

The Determination of a New Trifluorinated Quinolone,Fleroxacin, Its N-Demethyl,and N-Oxide Metabolites in Plasma and Urine by High Performance Liquid Chromatography with Fluorescence Detection

Abstract

A liquid chromatographic method is described for the determination of the new fluoroquinolone Ro 23–6240 and its N-demethyl and N-oxide metabolites in plasma and urine. The three substances were extracted from aqueous solution with dichloromethane/isopropanol containing sodium dodecyl sulphate. After evaporation and reconstitution, samples were analysed on a reversed-phase column using ion pair chromatography and fluorescence detection. The limit of quantification was 10–20 ng/ml (RSD 4%) using a 0.5 ml plasma sample, and the inter assay precision was 3–10% over the concentration range 50 ng/ml to 20 μg/ml. Recovery from plasma was 81% (RSD 10%) over the range 10 ng/ml to 5 μg/ml. The method has been applied successfully to the analysis of several thousand samples from human pharmacokinetic studies. Care has to be taken to avoid exposure of samples to direct sunlight, and the use of opaque vessels for sample storage and handling is recommended.     

An Improved Microanalytical Procedure for the Quantitation of Procainamide and N-Acetyl Procainamide in Serum by High-Performance Liquid Chromatography

Abstract

A high-performance liquid chromatographic method for analysis of procainamide (PA), and N-acetyl procainamide (NAPA) is presented. Sample preparation employs a simple base-acid double extraction procedure and analysis is carried out on a reverse phase chromatographic system using a μBondapak C₁₈ column and buffered aqueous acetonitrile as the mobile phase. The extraction procedure gives quantitative recovery of both PA and NAPA, and chromatographic results show that drug levels of as low as 0.3 mg per liter of serum can be conveniently analyzed without significant background interferences. The small volume (0.2 ml) of serum needed to perform an analysis makes this method suitable for pharmacokinetic studies in humans and animals as well as for clinical therapeutic drug monitoring studies.     

Automated Solid Phase Extraction and Hplc Analysis of Ibuprofen in Plasma

Abstract

Ibuprofen is a non-steroidal anti-inflammatory drug, widely used in arthritis and other disorders. We describe a high pressure liquid chromatographic (HPLC) method for the analysis of ibuprofen in plasma, using an automated solid phase extraction technique (the Varian AASP^R). In this method ibuprofen was extracted from 0.5 ml of plasma by application to a C₂ extraction cartridge followed by “on line” elution with the HPLC mobile phase (55% acetonitrile / 45% 0.02 H phosphate buffer; pH 3.0), at a flow rate of 1.5 ml/min. The analytical column was a Nucleosil C₁₈ column and the fluorescence detector was set at 253 nm (excitation wavelength) and 300 nm (emission wavelength). Chromatography was complete in less than 10 mins and the limit of detection was 1.3 /μg/ml. The method is linear through the range of 1.0 to 100.0 /μg/ml with a mean correlation coefficient of 0.9964. Absolute recovery of ibuprofen from the spiked plasma samples ranged from 77.8% to 86.5%. The method was shown to be precise within 11% C.V. and accurate to within 8% over the concentration range studied.     

A Rapid Liquid Chromatographic Method for Determination of Flecainide in Human Blood Plasma Using Ultraviolet Detection

Abstract

A liquid chromatographic method for the assay of the antiarrhythmic drug flecainide in plasma has been developed. The method is rapid, simple and with sufficient detection sensitivity to render it suitable for therapeutic drug monitoring. Flecainide and added internal standard, a non-fluorinated analogue, were extracted by a single ether extraction from alkalinized plasma followed by a back-extraction of the ether with dilute phosphoric acid. A portion of the acid extract was then applied directly to a 30 cm ODS column eluting isocratically with 30% acetonitrile in water containing 0.01M dibutylamine phosphate. Monitoring was by ultraviolet detection at 214 nm and the total run time was 8 min. This method is specific and can quantitate plasma levels to less than 30 ng/ml (free base) from 0.5 ml of plasma without interference from antiarrhythmic drugs commonly used in therapy.     

Development and validation of a liquid chromatography–tandem mass spectrometry method for the simultaneous analysis of androgens,estrogens, glucocorticoids and progestagens in human serum

We present a liquid chromatography tandem mass spectrometry method for the simultaneous analysis of 16 endogenous steroids (androgens, estrogens, glucocorticoids and progestogens) in human serum. Samples (250 μl of matrix) were extracted with t-butylmethyl ether prior to LC–MS/MS analysis. The chromatographic separation was achieved on a reversed-phase column using a methanol–water gradient. The HPLC was coupled to a triple quadrupole mass spectrometer equipped with an electrospray ionization source with acquisition in multiple reaction monitoring mode. The method was validated using surrogate matrices and human serum samples. The specificity of the method was confirmed for all of the considered steroids; linearity was also assessed (R² > 0.99, lack-of-fit test) in the ranges of concentrations investigated. The lower limits of quantification were in the range 10–400 pg/ml depending on the target steroid. Accuracy was in the range 85–115% for all target steroids except for the lower limit of quantitation levels where it was 80–120%. The extraction recovery was always >65%. No significant matrix effects were observed. To test the reliability of the method, the analysis of serum samples collected from 10 healthy subjects (5 M/5F) was performed. The present method can be used to identify the trajectories of deviation from the concentration normality ranges applied to disorders of the gonadal and adrenal axes.     

Cyclodextrin Bonded Phase for Liquid Chromatographic Separation and Analysis of Some Oral Contraceptives

Abstract

A specific and sensitive analytical HPLC procedure was described for quantitative determination of ethinylestradiol and norethisterone acetate (Anovlar 1) and ethinylestradiol and norgestrel (Primovlar) in tablet formulation. These steroids were extracted from the tablets with methanol. The steroids were then determined with high performance liquid Chromatograph-Cyclobond 1 column using mobile phase phosphate buffer pH 7.0: methanol (60:40), flow rate 0.5 ml min^?1 and the detection was effected spectrophotometrically at 280 nm, using variable wavelength UV detector.

There was > 99.3% recovery from synthetic mixtures and the coefficient of variation was < 2.0% for the formulations investigated. The method is highly quantitative and reproducible.     

Characterization of Mechanisms of Pesticide Retention in Soils Using the Supercritical Fluid Extraction Technique

Abstract

This research determined the relative effectiveness of supercritical fluid extraction (SFE) in extracting atrazine and its metabolites from soils which had been treated with atrazine for varying periods of time in order to characterize binding mechanisms. Aqueous methanol extraction was more effective than SFE in removing ¹⁴C atrazine residues from “aged” soils. The more polar the solvent system, the more ¹⁴C-atrazine residues were extracted. The order of polarity and extractability was aqueous methanol > SF-CO₂/5% methanol > SF-CO². Atrazine extraction efficiency using SF-CO₂, and SF-CO₂/.5% methanol decreased as samples “aged” in the field. The less than complete recovery of atrazine residues using the SFE technique could be seen as an indication that different binding mechanisms were involved in the retention of atrazine as well as its metabolites and that the binding mechanisms changed with time.     

A Simple and Rapid Reversed Phase High Performance Liquid Chromatographic Method for Quantification of Alprazolam and α-Hydroxyalprazolam in Plasma

Abstract

A simple and rapid reversed-phase liquid chromatographic method for the determination of alprazolam and a-hydroxyalprazolam in plasma is described. Flunictrazepam was used as internal standard. Plasma samples were buffered with sodium borate and extracted with dichloromethane /n-pentane 4:6 v/v for 60 sec on a vortex apparatus. Extraction solvent was evaporated to dryness and extraction residues were reconstituted in the mobile phase. Samples were chromatographed on a 5μ Lichrospher RP-18 column (25cm × 4mm i. d) using acetonitrile/water 40:60 v/v as the mobile phase. The column effluent was monitored at 230nm. The lower limit of detection was 1ng/ml for alprazolam and a-hydroxyalprazolam while the lower limit of quantification was 2ng/ml for both compounds. Peak height and plasma     

Determination of Benzodiazepines in Serum by High Performance Liquid Chromatography Using Radially Compressed Columns and an Aqueous Methanolic Mobile Phase

Abstract

Diazepam, oxazepam and N-desmethyldiazepam are determined by high performance liquid chromatography using a radially compressed C18 column and an aqueous methanolic mobile phase. The chromatographic separation is completed within 10 minutes. The drugs are recovered from serum by extraction with hexane:ethyl acetate 70:30, v/v.

The method is linear in the range 50-1600 ng/ml for all the drugs, Coefficients of variation are less than 6.2% for two studied concentration levels.     

A Rapid Method for Determination of Progesterone By Reversed-Phase Liquid Chromatography from Aqueous Media

ABSTRACT

A simple reversed-phase liquid chromatographic method to assay progesterone in aqueous receiving medium, following in vitro skin permeation studies is presented. Progesterone was analysed using 5 μm LichroCART® RP-18 column (125 × 4 mm i.d.), after extraction with chloroform. The mobile phase used was methanol:water (70:30) at a flow rate of 1 ml/min. Detection was carried out at 254 nm at room temperature. The method showed a mean recovery of 99% for progesterone, and intra-assay and inter-assay coefficients of variation were below 2%. The proposed method was validated for linearity, specificity, precision and accuracy and showed to be useful for analysis of progesterone in in vitro skin permeation studies.     

High Performance Liquid Chromatographic Assay for Basic Amine Drugs in Plasma and Urine Using a Silica Gel Column and an Aqueous Mobile Phase. II. Chlorpheniramine

Abstract

A high performance liquid chromatographic [HPLC] method that involves the use of a silica gel column and an aqueous mobile phase for quantitation of chlorpheniramine in plasma and urine is presented. Alkalinized samples are cleaned by extraction with pentane [containing 1% CH₃CN], and the extraction is followed by evaporating the solvent and reconstituting the residue in a small amount of mobile phase. An aliquot of this solution is analyzed by an HPLC system with an Ultrasphere Si Column, an aqueous mobile phase at pH 7 containing 60% CH₃CN and 7.5 mM [NH₄]₂HPO₄, and UV detection at 200 nm. Although the average recovery of extraction is 58% ± SD 10%, the detection limit for the method is 0.7 ng/ml in plasma and 100 ng/ml in urine [s/n = 3] for 0.5 ml samples. The coefficients of variation [CV] on the results of samples run to measure interday and intraday precision and the bias on control samples were all 10% or less. We have used the method in a bioavailability study of a controlled release formulation involving over 1000 samples.